drugset / Trial / NCT03923959

Evaluation of TXA Prior to Surgery in the Geriatric Hip Fracture Population

NCT03923959

Phase 3 Completed 283 enrolled Lancaster General Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The overall design of the study is a prospective, double-blinded, randomized study in the geriatric hip fracture population comparing those who receive intravenous tranexamic acid prior to incision to those who receive a placebo.

Timeline

Start
2020-02-01
Primary completion
2022-12-09
Completion
2022-12-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.